Possible The power of AI, from curing cancer to ballot boxes
41 snips
Dec 17, 2025 
Siddhartha Mukherjee, a Pulitzer Prize-winning oncologist and the mind behind Manas AI, dives deep into the transformative role of AI in medicine. He highlights breakthroughs in cancer immunotherapy, including engineered T-cells that tackle previously unsolvable cases. The conversation extends to AI's potential in drug discovery, creating a 'molecular oracle' for new treatments. They also explore Silicon Valley's evolving culture, advocating for technology that prioritizes humanity and truth, especially as AI influences public discourse and political opinion.
AI Snips
Chapters
Books
Transcript
Episode notes
Early Detection Creates New Dilemmas
- Early detection technologies like blood tests and full-body scans have transformed possibilities.
- The key question now is what to do when we find early or incidental signals.
Founding Manus To Be AI-Native
- Reid Hoffman, Ujwal Singh, and Siddhartha Mukherjee co-founded Manus AI to apply AI to drug creation.
- Manus focuses on AI-native drug discovery, using models to design molecules that block cancer targets.
AI As Molecular Oracle
- Manus treats AI as the creative engine for molecular design, not merely data management.
- They aim to place atoms with atomic precision to block protein activity driving cancer.
